First evidence of in vivo pro-angiogenic activity of cerebrospinal fluid samples from multiple sclerosis patients

Clinical and Experimental Medicine

Volumn 16, Issue 1, 2016, Pages 103-107

  Ribatti, Domenico ^a,b   Iaffaldano, Pietro ^a   Marinaccio, Christian ^a   Trojano, Maria ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Angiogenesis; Cerebrospinal fluid; Chorioallantoic membrane; Multiple sclerosis

Indexed keywords

ADULT; ANGIOGENESIS; ARTICLE; CEREBROSPINAL FLUID; CHORIOALLANTOIC MEMBRANE ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISABILITY; DISEASE COURSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; IN VIVO STUDY; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; ANIMAL; CHICK EMBRYO; CHORIOALLANTOIS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; VASCULARIZATION;

VASCULOTROPIN A;

ADULT; ANIMALS; CEREBROSPINAL FLUID; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84957955661     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-014-0334-1     Document Type: Article

References (18)

1. Benvenuto R, Paroli M, Buttinelli C, Franco A, Barnaba V, Fieschi C, et al. Tumor necrosis factor-alpha and interferon-gamma synthesis by cerebrospinal fluid-derived T cell clones in multiple sclerosis. Ann N Y Acad Sci. 1992;650:341–6.
2. Croll SD, Ransohoff RM, Cai N, Zhang Q, Martin FJ, Wei T, et al. VEGF-mediated inflammation preceds angiogenesis in adult brain. Exp Neurol. 2004;187(2):388–402.
3. Graumann U, Reynolds R, Steck AJ, Schaeren-Wiemers N. Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol. 2003;13(4):554–73.
4. Greenberg DA, Jin K. From angiogenesis to neuropathology. Nature. 2005;438(7070):954–9.
5. Holley JE, Newcombe J, Whatmore JL, Gutowski NJ. Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter. Neurosci Lett. 2010;470(1):65–70.
6. Iacobaeus E, Amoudruz P, Strom M, Khademi M, Brundin L, Hillert J, et al. The expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosis. PLoS One. 2011;6(5):e19138.
7. Lassmann H. Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J Neurol Sci. 2003;206(2):187–91.
8. Proescholdt MA, Heiss JD, Walbridge S, Muhlhauser J, Capogrossi MC, Oldfield EH, et al. Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J Neuropathol Exp Neurol. 1999;58(6):613–27.
9. Proescholdt MA, Jacobson S, Tresser N, Oldfield EH, Merrill MJ. Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol. 2002;61(10):914–25.
10. Rieckmann P, Albrecht M, Ehrenreich H, Weber T, Michel U. Semi-quantitative analysis of cytokine gene expression in blood and cerebrospinal fluid cells by reverse transcriptase polymerase chain reaction. Res Exp Med (Berl). 1995;195(1):17–29.
11. Ribatti D, Nico B, Vacca A, Presta M. The gelatin sponge-chorioallantoic membrane assay. Nat Protoc. 2006;1(1):85–91.
12. Ribatti D. Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis. Int Rev Cell Mol Biol. 2008;270:181–224.
13. Ruiz de Aldomovar C, Lambrechts D, Mazzone M, Carmeliet P. Role and therapeutic potential of VEGF in the nervous system. Physiol Rev. 2009;89(2):607–48.
14. Sarchielli P, Di Filippo M, Ercolani MV, Chiasserini D, Mattioni A, Bonucci M, et al. Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. Neurosci Lett. 2008;435(3):223–8.
15. Seabrook TJ, Littlewood-Evans A, Brinkmann V, Pollinger B, Schnell C, Hiestand PC. Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions. J Neuroinflamm. 2010;7:95.
16. Suarez S, Ballmer-Hofer K. VEGF transiently disrupts gap junctional communication in endothelial cells. J Cell Sci. 2001;114(Pt 6):1229–35.
17. Tham E, Gielen AW, Khademi M, Martin C, Piehl F. Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis. Scand J Immunol. 2006;64(6):609–22.
18. Theoharides TC, Konstantinidou AD. Corticotropin-releasing hormone and the blood–brain-barrier. Front Biosci. 2007;12:1615–28.